Kymera Therapeutics, Inc.
KYMR
54 insider filings · Latest: Oct 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Jun 26 10:13 PM | BVF PARTNERS L P/IL | Proposed Sale | 1,630,658 | $116.46 | $189.9M | — | View → |
| Jun 26, 2026 | Jun 26 8:52 PM | Atlas Venture Fund X, LP | Proposed Sale | 410,427 | $116.46 | $47.8M | — | View → |
| Jun 26, 2026 | Jun 26 8:51 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 57,451 | $116.46 | $6.7M | — | View → |
| Jun 25, 2026 | Jun 26 1:56 AM | Bruce BoothDirector | Sale | 285,684 | $121.86 | $34.8M | 529,718(I) | View → |
| Jun 25, 2026 | Jun 26 1:55 AM | Bruce BoothDirector | Sale | 262,637 | $115.39 | $30.3M | 564,668(I) | View → |
| Jun 24, 2026 | Jun 26 1:55 AM | Bruce BoothDirector | Sale | 134,720 | $100.51 | $13.5M | 597,047(I) | View → |
| Jun 23, 2026 | Jun 26 1:55 AM | Bruce BoothDirector | Sale | 1,408 | $99.98 | $140.8K | 613,589(I) | View → |
| Jun 25, 2026 | Jun 25 10:00 PM | Noah GoodmanChief Business Officer | Sale | 5,000 | $114.00 | $570.0K | 50,195.438(D) | View → |
| Jun 25, 2026 | Jun 25 9:26 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 67,329 | $99.87 | $6.7M | — | View → |
| Jun 25, 2026 | Jun 25 9:25 PM | Atlas Venture Fund X, LP | Proposed Sale | 480,992 | $99.87 | $48.0M | — | View → |
| Jun 25, 2026 | Jun 25 8:27 PM | NOAH GOODMAN | Proposed Sale | 5,000 | $99.87 | $499.4K | — | View → |
| Jun 24, 2026 | Jun 24 9:30 PM | Atlas Venture Fund X, LP | Proposed Sale | 118,178 | $98.25 | $11.6M | — | View → |
| Jun 24, 2026 | Jun 24 9:29 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 16,542 | $98.25 | $1.6M | — | View → |
| Jun 23, 2026 | Jun 23 10:14 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 173 | $99.45 | $17.2K | — | View → |
| Jun 23, 2026 | Jun 23 10:14 PM | Atlas Venture Fund X, LP | Proposed Sale | 1,235 | $99.45 | $122.8K | — | View → |
| Jun 22, 2026 | Jun 23 1:02 AM | Bruce BoothDirector | Sale | 31,798 | $103.75 | $3.3M | 613,762(I) | View → |
| Jun 22, 2026 | Jun 23 1:01 AM | Bruce BoothDirector | Sale | 246,330 | $98.52 | $24.3M | 617,663(I) | View → |
| Jun 18, 2026 | Jun 23 1:01 AM | Bruce BoothDirector | Sale | 115,056 | $91.01 | $10.5M | 647,914(I) | View → |
| Jun 17, 2026 | Jun 23 1:01 AM | Bruce BoothDirector | Sale | 116,812 | $90.34 | $10.6M | 662,042(I) | View → |
| Jun 22, 2026 | Jun 22 9:47 PM | Noah GoodmanChief Business Officer | Sale | 2,500 | $99.00 | $247.5K | 50,195.438(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4 11:00 PM | Jared GollobChief Medical Officer | Grant/Award | 35,300 | $90.10 | 35,300(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Bruce N. JacobsChief Financial Officer | Grant/Award | 35,300 | $90.10 | 35,300(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Nello MainolfiDirector, Chief Executive Officer | Grant/Award | 215,000 | $90.10 | 215,000(D) | View → |
| Feb 25, 2026 | Feb 25 10:24 PM | Nello MainolfiDirector, Chief Executive Officer | Option Exercise | 30,000 | $2.08 | 245,559(D) | View → |
| Feb 20, 2026 | Feb 20 10:30 PM | Pamela EspositoDirector | Option Exercise | 2,500 | $49.10 | 2,500(D) | View → |
| Jan 20, 2026 | Jan 20 11:30 PM | Pamela EspositoDirector | Option Exercise | 5,500 | $49.10 | 5,000(D) | View → |
| Dec 31, 2025 | Dec 31 10:23 PM | Nello MainolfiDirector, Chief Executive Officer | Option Exercise | 30,000 | $2.08 | 275,559(D) | View → |
← Previous
Page 3 of 3